Our analysis revealed, in both the TCGA and ACRG cohorts, no significant association between MAP4K4 expression and clinical characteristics, including age, tumor staging, and Lauren classification (Table 1 and Table 2). This evidence concerns the gene MAP4K4 and neoplasm.